 Sanofi, a renowned French pharmaceutical company, is reportedly considering the acquisition of the American drug manufacturer Insmed. This potential move has led to an increase in Insmed's stock by 15%, while Sanofi's shares have seen a decline of 3%.

[HashDegen](https://t.me/powdegen)